Contraceptive Technology Update – July 1, 2016
July 1, 2016
View Issues
-
Success with Teen Pregnancy Rate, But There Is More Work Left to Do
Just-published data indicate that births among Hispanic and black teens have dropped by almost half since 2006, which mirrors a substantial national decline. Births to all American teenagers have dropped more than 40% within the past decade.
-
Update on Contraceptive Implant — What Family Planners Need to Know
The contraceptive implant Nexplanon (Merck, Whitehouse Station, NJ) offers top-tier effectiveness against unintended pregnancy. How can you identify appropriate candidates, present counseling tips on the contraceptive and noncontraceptive benefits, and recognize and treat side effects and rare complications?
-
Data Suggest Hormonal Therapy Doesn’t Increase VTE Risk in Women on Anticoagulant Therapy
Women on anticoagulant therapy can take estrogen-containing contraception or hormone therapy without an increased risk of blood clots or uterine bleeding, findings from a recent study suggest.
-
Medicaid Pushes Forward on Family Planning
With the end of the Obama administration rapidly approaching, federal agencies have stepped up their efforts to finalize long-brewing regulations and guidance. CMS has been particularly active. In April 2016, the agency issued three documents that all have considerable importance for family planning services and providers under Medicaid.
-
A Low-Dose Estrogen Capsule Examined as Possibility for Vaginal Atrophy
About 32 million postmenopausal women in the United States are affected by vulvar and vaginal atrophy, which can cause painful sexual activity and urination, as well as vaginal dryness, itching, and irritation. Recent data presented at ENDO 2016, the annual meeting of the Endocrine Society, suggests an investigational low-dose vaginal estrogen capsule may help relieve such symptoms.
-
Screening for Ovarian Cancer: Helpful or Harmful?
Ovarian cancer has the highest mortality of any of the gynecologic cancers. Due to the poor prognosis associated with this disease, researchers have been searching for 50 years for an early detection tool.